Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Cancer spread to the bone, Prostate cancer, Secondary cancers
Closed
Phase 3
This study is looking at circulating tumour cells (CTCs) to see if it can help doctors decide when to change treatment for prostate cancer. CTCs are tumour cells that have broken away from prostate cancer and are circulating in the blood.
It is for men with advanced prostate cancer that has spread to the bones after treatment with .
Recruitment start: 11 January 2017
Recruitment end: 2 May 2019
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Professor Johann de Bono
Institute of Cancer Research (ICR)
Janssen Diagnostics
Menarini Silicon Biosystems
Movember Foundation
National Institute for Health Research (NIHR)
Prostate Cancer UK
Sanofi
Last reviewed: 1 July 2019
CRUK internal database number: 14895
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
